LOW vs PPCB · P/E 18, rev $86.29B vs P/E 0.0, $3.9M cap
Lowe's Companies Inc (LOW) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
PPCB does not have a complete income-statement cache yet.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the LOW and PPCB stock pages for the full models.
Not investment advice.